Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edgewise Therapeutics, Inc.

11.57
-0.9300-7.44%
Post-market: 11.570.00000.00%18:38 EDT
Volume:1.33M
Turnover:15.39M
Market Cap:1.22B
PE:-7.99
High:12.25
Open:12.09
Low:11.23
Close:12.50
Loading ...

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

Zacks
·
Yesterday

Edgewise Therapeutics (EWTX): Among Unstoppable Stocks That Could Double Your Money

Insider Monkey
·
06 Apr

Major Stake Acquisitions Signal Confidence in Edgewise Therapeutics

TIPRANKS
·
05 Apr

Edgewise Therapeutics Downgraded Following Safety Issues in Heart Drug Trial

GuruFocus.com
·
04 Apr

Edgewise Therapeutics Says Believes Atrial Fibrillation Not Driven by EDG-7500 in Phase 2 Trial, RBC Says

MT Newswires Live
·
04 Apr

Edgewise Therapeutics Cut to Sector Perform From Sector Outperform by Scotiabank

Dow Jones
·
03 Apr

RBC Lowers Price Target on Edgewise Therapeutics to $52 From $56, Keeps Outperform, Speculative Risk

MT Newswires Live
·
03 Apr

U.S. RESEARCH ROUNDUP-Alphabet, Amazon, Meta

Reuters
·
03 Apr

Edgewise Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
03 Apr

BUZZ-U.S. STOCKS ON THE MOVE-M-tron, Rocket Companies, TKO Group

Reuters
·
03 Apr

BUZZ-Edgewise falls on safety, efficacy doubts for heart disease drug

Reuters
·
02 Apr

Edgewise Therapeutics Shares Down 32.9% After Mid-Stage Trial Data of Co's Heart Disease Drug

THOMSON REUTERS
·
02 Apr

Edgewise Therapeutics 9.935M share Spot Secondary priced at $20.13

TIPRANKS
·
02 Apr

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Ahead of US Tariffs Announcement

MT Newswires Live
·
02 Apr

Morning Brew: Folksam Divests Tesla Amid Labor Concerns

GuruFocus
·
02 Apr

Edgewise Therapeutics Shares Tumble on Underwritten Public Offering Pricing

Dow Jones
·
02 Apr

Edgewise Therapeutics Reports New Results From Phase 2 Hypertrophic Cardiomyopathy Trial

MT Newswires Live
·
02 Apr

Edgewise Therapeutics Prices $200 Million Offering

MT Newswires Live
·
02 Apr

BRIEF-Edgewise Therapeutics Announces Pricing Of $200 Million Underwritten Offering Of Common Stock

Reuters
·
02 Apr

Edgewise Therapeutics Announces Pricing of $200 Million Underwritten Offering of Common Stock

THOMSON REUTERS
·
02 Apr